Join
Live feed
·
INSIDERFilingvia Quantisnow
Akari Therapeutics plc logo

Director Neal James R was granted 8,000,000 units of Ordinary Shares, increasing direct ownership by 33% to 32,216,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKTX· Akari Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTX (Akari Therapeutics plc) and more on Quantisnow.